Stock MRRC.F WAYLAND GROUP CORP.
Add to a list
To use this feature you must be a member
Log inSign up

All News Wayland Group Corp.

Equities

MRRC.F

CA9442041062

Market Closed - OTC Markets
Other stock markets
 14:11:35 2024-05-16 EDT 		5-day change 1st Jan Change
0.000001 USD 0.00% Intraday chart for Wayland Group Corp. 0.00% 0.00%
2021 RG5 Investments Inc. and Albert Sheeler cancelled the acquisition of Gardina Pharmaceutical SAS from Wayland Group Corp.. CI
2020 Wayland Group Corp. Announces Board and CEO Resignation CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
"Class (Action) Dismissed!": Recent Interpretations Of Section 29.1 Of The Class Proceedings Act, 1992
AQ
RG5 Investments Inc. and Albert Sheeler cancelled the acquisition of Gardina Pharmaceutical SAS from Wayland Group Corp..
CI
HEXO : A New Crop Of Securities Class Actions And Amendments To The Class Proceedings Act
AQ
Wayland Group Corp. Announces Board and CEO Resignation
CI
CanAdelaar B.V. completed the acquisition of Maricann Inc. and certain certain other property from Wayland Group Corp. and Nanoleaf Technologies Inc.
CI
CanAdelaar B.V. agreed to acquire Maricann Inc. and certain certain other property from Wayland Group Corp. and Nanoleaf Technologies Inc. for CAD 12.4 million.
CI
RG5 Investments Inc. and Albert Sheeler agreed to acquire Gardina Pharmaceutical SAS from Wayland Group Corp. for CAD 0.3 million.
CI
Wayland Group Corp. Announces Management Changes
CI
Wayland Announces Court Approval of Amended DIP Facility
CI
Wayland Group cancelled the acquisition of 97% stake in Agro Ivica Dumandzic S.R.L.
CI
Maricann Group Inc. cancelled the acquisition of 51% stake in Theros Pharma Ltd.
CI
Wayland Group Corp. cancelled the acquisition of 50.1% stake in Tropicana Pty Ltd.
CI
ICC International Cannabis Corp. (CNSX:WRLD.U) cancelled the acquisition of 49.9% stake in Maricann B.V. from Wayland Group Corp..
CI
Maricann Group Inc. cancelled the acquisition of Colma Pharmaceutical SAS on November 6, 2019.
CI
Wayland Group Corp. Provides Corporate Update on Transaction, Construction and Operational Progress; Revises Revenue Guidance for 2019; Plans to Plan New Plants
CI
Wayland Group Receives $5 Million Bridge Loan from Cryptologic
CI
Wayland Group Corp. Announces Executive Changes
CI
Wayland Group Announces Changes to the Board of Directors
CI
Wayland Group Corp. Announces Delay in Filing in Audited Annual Financial Statements for the Year Ended December 31, 2018
CI
Wayland Group Names Matthew McLeod as President
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MRRC.F Stock
  4. News Wayland Group Corp.